← Back to Patent Explorer
US4710489A Expired / Lapsed US ⏱️ 0.0 years remaining

Glutathione delivery system

Assignee: Cornell Research Foundation Inc
•
Filing: 1986-01-10
•
Granted: 1987-12-01
•
Expires: 2006-01-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Substantially pure alkyl monoesters of glutathione, the ester being of the glycine carboxylic acid, and use thereof to increase cellular levels of glutathione.

Inventors

  • 👤 Alton Meister

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 05:23
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/02; C07K5/0215

Claims Analysis

Total Claims: 26
Claim 1
Independent Claim 56 words
A method for increasing cellular levels in animals of glutathione, comprising: administering a methyl and/or ethyl monoester of glutathione in substantially pure form in an amount to increase intracellular levels of glutathione, whereby said ester is transported into said cells and hydrolyzed intracellularly to glutathione, said ester being of the glycine carboxylic acid group of glutathione.
Claim 2
Independent Claim 56 words
A method for increasing cellular levels in animals of glutathione, comprising: administering a methyl and/or ethyl monoester of glutathione in substantially pure form in an amount to increase intracellular levels of glutathione, whereby said ester is transported into said cells and hydrolyzed intracellularly to glutathione, said ester being of the glycine carboxylic acid group of glutathione.
Claim 3
Dependent Claim 12 words
The method of claim 1 wherein said ester is the methyl ester.
Claim 4
Dependent Claim 12 words
The method of claim 1 wherein said ester is the ethyl ester.
Claim 5
Dependent Claim 25 words
The method of claim 1 wherein said esterified glutathione is administered in a dosage of 0.5 to 10 millimoles per kilogram of animal body weight.
Claim 6
Dependent Claim 13 words
The method of claim 4 wherein said esterified glutathione is administered by injection.
Claim 7
Independent Claim 43 words
A method for detoxification of a drug in animals comprising: administering a substantially pure monomethyl or monoethyl ester of glutathione with the proviso that only the glycine carboxyl group of glutathione is esterified, in a dosage to detoxify said animal of said drug.
Claim 8
Independent Claim 43 words
A method for detoxification of a drug in animals comprising: administering a substantially pure monomethyl or monoethyl ester of glutathione with the proviso that only the glycine carboxyl group of glutathione is esterified, in a dosage to detoxify said animal of said drug.
Claim 9
Independent Claim 45 words
A method for increasing radiation resistance of an animal comprising: administering a substantially pure monomethyl or monoethyl ester of glutathione, with the proviso that only the glycine carboxyl group of glutathione is esterified, in a dosage sufficient to increase the radiation resistance of said animal.
Claim 10
Independent Claim 45 words
A method for increasing radiation resistance of an animal comprising: administering a substantially pure monomethyl or monoethyl ester of glutathione, with the proviso that only the glycine carboxyl group of glutathione is esterified, in a dosage sufficient to increase the radiation resistance of said animal.
Claim 11
Dependent Claim 10 words
The method of claim 6 wherein said drug is acetaminophen.
Claim 12
Independent Claim 58 words
A method for increasing the resistance of an animal to the effects of reactive oxygen intermediates comprising: administering a substantially pure monomethyl or monoethyl ester of glutathione, with the proviso that only the glycine carboxyl group of glutathione is esterified, in a dosage sufficient to increase the resistance of said animal to the effects of reactive oxygen intermediates.
Claim 13
Independent Claim 58 words
A method for increasing the resistance of an animal to the effects of reactive oxygen intermediates comprising: administering a substantially pure monomethyl or monoethyl ester of glutathione, with the proviso that only the glycine carboxyl group of glutathione is esterified, in a dosage sufficient to increase the resistance of said animal to the effects of reactive oxygen intermediates.
Claim 14
Independent Claim 60 words
A method for increasing cellular levels in animals of glutathione, comprising: administering an alkyl (C 3 to C 10 ) monoester of glutathione in substantially pure form in an amount to increase intracellular levels of glutathione, whereby said ester is transported into said cells and hydrolyzed intracellularly to glutathione, said ester being of the glycine carboxylic acid group of glutathione.
Claim 15
Independent Claim 60 words
A method for increasing cellular levels in animals of glutathione, comprising: administering an alkyl (C 3 to C 10 ) monoester of glutathione in substantially pure form in an amount to increase intracellular levels of glutathione, whereby said ester is transported into said cells and hydrolyzed intracellularly to glutathione, said ester being of the glycine carboxylic acid group of glutathione.
Claim 16
Dependent Claim 12 words
The method of claim 10 wherein said ester is a propyl ester.
Claim 17
Dependent Claim 12 words
The method of claim 10 wherein said ester is a butyl ester.
Claim 18
Dependent Claim 25 words
The method of claim 10 wherein said esterified glutathione is administered in a dosage of 0.5 to 10 millimoles per kilogram of animal body weight.
Claim 19
Dependent Claim 13 words
The method of claim 10 wherein said esterified glutathione is administered by injection.
Claim 20
Independent Claim 47 words
A method for detoxification of a drug in animals comprising: administering a substantially pure alkyl (C 3 to C 10 ) monoester of glutathione, with the proviso that only the glycine carboxyl group of glutathione is esterified, in a dosage to detoxify said animal of said drug.
Claim 21
Independent Claim 47 words
A method for detoxification of a drug in animals comprising: administering a substantially pure alkyl (C 3 to C 10 ) monoester of glutathione, with the proviso that only the glycine carboxyl group of glutathione is esterified, in a dosage to detoxify said animal of said drug.
Claim 22
Independent Claim 49 words
A method for increasing radiation resistance of an animal comprising: administering a substantially pure alkyl (C 3 to C 10 ) monoester of glutathione with the proviso that only the glycine carboxyl group of glutathione is esterified, in a dosage sufficient to increase the radiation resistance of said animal.
Claim 23
Independent Claim 49 words
A method for increasing radiation resistance of an animal comprising: administering a substantially pure alkyl (C 3 to C 10 ) monoester of glutathione with the proviso that only the glycine carboxyl group of glutathione is esterified, in a dosage sufficient to increase the radiation resistance of said animal.
Claim 24
Dependent Claim 10 words
The method of claim 15 wherein said drug is acetaminophen.
Claim 25
Independent Claim 61 words
A method for increasing the resistance of an animal to the effects of reactive oxygen intermediates comprising: administering a substantially pure (C 3 to C 10 ) monoester of glutathione, with the proviso that only the glycine carboxyl group of glutathione is esterified, in a dosage sufficient to increase the resistance of said animal to the effects of reactive oxygen intermediates.
Claim 26
Independent Claim 61 words
A method for increasing the resistance of an animal to the effects of reactive oxygen intermediates comprising: administering a substantially pure (C 3 to C 10 ) monoester of glutathione, with the proviso that only the glycine carboxyl group of glutathione is esterified, in a dosage sufficient to increase the resistance of said animal to the effects of reactive oxygen intermediates.

References Cited (Backward Citations)

US2250553A Cited
US2376186A Cited
US2702799A Cited
US2711989A Cited
US2900375A Cited
US2938023A Cited
JPH108399A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-11-30 1991-06-01 1991-12-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-11-30 1995-06-01 1995-12-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-11-30 1999-06-01 1999-12-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag